Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Barcelona
Clinical trial register · Spain

Clinical Trials in Barcelona, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5875 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5875
Studies in scope
all four open statuses
3096
Recruiting now
open to new participants
1137
Lead sponsors
across recruiting studies
Top sites
Barcelona 41 Madrid 40 Seville 21 Málaga 12 Santiago de Compostela 11
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca188 Merck Sharp & Dohme LLC113 Novartis Pharmaceuticals111 Janssen Research & Development, LLC96 Hoffmann-La Roche85 Clear sponsor filter
Site location
Barcelona41 Madrid40 Seville21 Málaga12 Santiago de Compostela11
All 52 locations
Target enrolment
to

Trials with a site in Barcelona

41 of 5875 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Recruiting
Sanofi
Phase 4
300
Barcelona, A Coruña, Madrid, San Cristóbal de La Laguna, Málaga, Sabadell
2026-05-12
Recruiting
Sanofi
Phase 2/3
526
Barcelona, L'Hospitalet de Llobregat, Málaga
2026-03-13
Recruiting
Sanofi
Phase 2
144
Bilbao, Barcelona, Seville, Córdoba, Málaga
2025-12-29
Recruiting
Sanofi
Phase 2
37
Esplugues de Llobregat, Barcelona, Madrid
2025-12-02
Recruiting
Sanofi
Observational
1,000
Barcelona, Santa Cruz de Tenerife, Alicante
2025-11-17
Recruiting
Sanofi
Phase 3
60
Barcelona, Burgos, Madrid, Murcia, San Cristóbal de La Laguna, Seville
2025-10-24
Recruiting
Sanofi
Phase 3
124
Barcelona, Madrid
2025-09-26
Recruiting
Sanofi
Phase 4
218
Santander, Barcelona, Pozuelo de Alarcón, Oviedo, Madrid
2025-09-22
Recruiting
Sanofi
Phase 3
942
Zaragoza, Badalona, Santander, Barcelona, Madrid
2025-09-17
Recruiting
Sanofi
Phase 2
30
Barcelona, Pamplona, Seville
2025-09-02
Recruiting
Sanofi
Phase 3
90
Seville, Bizkaia, Barcelona, Majadahonda, Madrid
2025-08-18
Recruiting
Sanofi
Phase 3
723
Santiago de Compostela, Seville, Esplugues de Llobregat, Bizkaia, Barcelona, Alcalá de Henares, Madrid, Pamplona
2025-08-06
By invitation
Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP
NCT06859099Polyneuropathy, Inflammatory Demyelinating, Chronic
DrugRiliprubart
Sanofi
Phase 3
300
Barcelona, Majadahonda, Pamplona, Málaga, Valencia
2025-04-01
Active, closed
Sanofi
Phase 3
231
Santiago de Compostela, Barcelona, Jerez de la Frontera, Majadahonda, Seville, Sabadell, Zaragoza
2025-02-12
Active, closed
Sanofi
Phase 3
216
Barcelona, Santander, L'Hospitalet de Llobregat, Pamplona, Madrid
2025-02-06
Recruiting
Sanofi
Phase 2
84
Seville, Barcelona, Córdoba, Madrid
2024-12-19
Active, closed
Sanofi
Observational
143
Santiago de Compostela, Esplugues de Llobregat, Oviedo, Seville, Alicante, Barcelona, Madrid, Málaga
2024-11-14
Active, closed
Sanofi
Phase 2
556
Santiago de Compostela, Badalona, Santander, Barcelona, Madrid, Benalmádena, Girona, Málaga
2024-11-07
Recruiting
Sanofi
Phase 1
87
Barcelona, Madrid
2024-10-30
By invitation
Sanofi
Phase 2
900
Barcelona, Madrid
2024-09-30
Active, closed
Sanofi
Phase 2
229
Barcelona, Chiclana de la Frontera, Las Palmas de Gran Canaria, Seville, Madrid, Málaga
2024-08-29
Recruiting
Sanofi
Phase 3
160
Santiago de Compostela, Barcelona, Majadahonda, Pamplona, Málaga, Sabadell, Santa Cruz de Tenerife, Valencia
2024-08-21
Active, closed
A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work
NCT06290128Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Polyneuropathy, Inflammatory Demyelinating, Chronic
DrugRiliprubart
Sanofi
Phase 3
109
Santiago de Compostela, Barcelona, Bilbao, Majadahonda, Pamplona, Oviedo, Sabadell, Santa Cruz de Tenerife
2024-07-12
Active, closed
A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.
NCT06372145Relapsing Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Progressive Relapsing Multiple Sclerosis
DrugTeriflunomide
Sanofi
Phase 3
2,500
A Coruña, Seville, Barcelona, L'Hospitalet de Llobregat, Barakaldo, Santiago de Compostela, Donostia / San Sebastian, Salt
2024-04-16
Active, closed
Sanofi
Phase 3
260
Santander, Barcelona, Madrid, Málaga, Salamanca, Seville, Valencia
2024-01-23
By invitation
Sanofi
Phase 3
90
Santiago de Compostela, Barcelona, Esplugues de Llobregat, Sabadell, Jerez de la Frontera, Madrid, Valencia
2024-01-03
Active, closed
Sanofi
Phase 3
943
Murcia, Barcelona, Barakaldo, L'Hospitalet de Llobregat, Donostia / San Sebastian, Girona, Las Palmas de Gran Canaria, Lleida
2023-12-27
Active, closed
Sanofi
Phase 3
1,655
Murcia, Barcelona, Barakaldo, Las Palmas de Gran Canaria, Pozuelo de Alarcón, Pontevedra, Seville, Córdoba
2023-12-13
Active, closed
Sanofi
Phase 2
197
Barcelona, Esplugues de Llobregat, Oviedo, Seville, Málaga, Valencia, Vitoria-Gasteiz
2023-12-11
Recruiting
Sanofi
Phase 3
180
Santander, Barcelona, A Coruña, Majadahonda, Valencia
2023-10-10
Recruiting
Sanofi
Phase 1/2
542
Barcelona, Madrid
2022-11-29
Active, closed
Sanofi
Phase 2
187
Barcelona
2022-11-25
Active, closed
Sanofi
Phase 2
48
Barcelona, Madrid
2022-06-09
Recruiting
Sanofi
Phase 3
284
Barcelona, Pontevedra, Alicante, Córdoba
2022-02-15
Active, closed
Sanofi
Phase 2
22
Barakaldo, Barcelona, Madrid, Seville
2021-12-07
Active, closed
Sanofi
Phase 2
129
Barcelona, Vigo
2021-06-07
Active, closed
Sanofi
Phase 3
337
Barcelona, Pamplona, Valencia, Madrid, Salamanca, Zaragoza
2020-06-16
Active, closed
Sanofi
Observational
1,860
Barcelona, Pozuelo de Alarcón, Mieres, Madrid
2019-08-15
Active, closed
Sanofi
Observational
955
Bilbao, Las Palmas de Gran Canaria, Majadahonda, Oviedo, Barakaldo, Barcelona, Madrid, Santiago de Compostela
2019-06-11
Recruiting
Sanofi
Phase 2
51
Esplugues de Llobregat, Barcelona, Madrid, Málaga, Valencia
2018-08-09
Active, closed
Sanofi
Phase 3
475
Barcelona, Madrid, Murcia
2017-12-07
Rows per page Showing 1–41 of 41
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-spain/city/barcelona

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,875 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 41 of those studies with a site in Barcelona that also match the filters currently applied.

How many clinical trials are recruiting in Barcelona?

19 of the 41 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 19 are active but closed to new participants, and 3 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Barcelona), 41 studies
PhaseStudiesRecruitingShare
Phase 319846.3%
Phase 213531.7%
Observational419.8%
Phase 4224.9%
Phase 1112.4%
Phase 1/2112.4%
Phase 2/3112.4%

Most active sponsors

Lead sponsors with the most studies (Barcelona)
Lead sponsorStudiesRecruiting
Sanofi4119
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.